Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01794845
Title Phase II Trial Using Erbitux+ Taxotere With Low Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Miami
Age Groups: adult
Covered Countries USA

No variant requirements are available.